Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
257
-
Total 13F shares, excl. options
-
55.7M
-
Shares change
-
-18.9M
-
Total reported value, excl. options
-
$797M
-
Value change
-
-$259M
-
Put/Call ratio
-
0.16
-
Number of buys
-
127
-
Number of sells
-
-104
-
Price
-
$14.32
Significant Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q1 2022
321 filings reported holding TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS as of Q1 2022.
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) has 257 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55.7M shares
.
Largest 10 shareholders include Mondrian Investment Partners LTD (4.32M shares), Parametric Portfolio Associates LLC (4.26M shares), GOLDMAN SACHS GROUP INC (4.24M shares), MACQUARIE GROUP LTD (4.22M shares), BANK OF AMERICA CORP /DE/ (3.39M shares), BlackRock Inc. (3.02M shares), FMR LLC (2.45M shares), NORTHERN TRUST CORP (2.22M shares), BRANDES INVESTMENT PARTNERS, LP (2.11M shares), and RENAISSANCE TECHNOLOGIES LLC (1.99M shares).
This table shows the top 257 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.